These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 26969752)

  • 1. Spectrum and Prevalence of CALM1-, CALM2-, and CALM3-Encoded Calmodulin Variants in Long QT Syndrome and Functional Characterization of a Novel Long QT Syndrome-Associated Calmodulin Missense Variant, E141G.
    Boczek NJ; Gomez-Hurtado N; Ye D; Calvert ML; Tester DJ; Kryshtal D; Hwang HS; Johnson CN; Chazin WJ; Loporcaro CG; Shah M; Papez AL; Lau YR; Kanter R; Knollmann BC; Ackerman MJ
    Circ Cardiovasc Genet; 2016 Apr; 9(2):136-146. PubMed ID: 26969752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel
    Kato K; Isbell HM; Fressart V; Denjoy I; Debbiche A; Itoh H; Poinsot J; George AL; Coulombe A; Shea MA; Guicheney P
    Circ Arrhythm Electrophysiol; 2022 Mar; 15(3):e010572. PubMed ID: 35225649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel CPVT-Associated Calmodulin Mutation in CALM3 (CALM3-A103V) Activates Arrhythmogenic Ca Waves and Sparks.
    Gomez-Hurtado N; Boczek NJ; Kryshtal DO; Johnson CN; Sun J; Nitu FR; Cornea RL; Chazin WJ; Calvert ML; Tester DJ; Ackerman MJ; Knollmann BC
    Circ Arrhythm Electrophysiol; 2016 Aug; 9(8):. PubMed ID: 27516456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The LQT-associated calmodulin mutant E141G induces disturbed Ca
    Su J; Gao Q; Yu L; Sun X; Feng R; Shao D; Yuan Y; Zhu Z; Sun X; Kameyama M; Hao L
    Am J Physiol Cell Physiol; 2020 May; 318(5):C991-C1004. PubMed ID: 32186935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Precision Medicine Approach to the Rescue of Function on Malignant Calmodulinopathic Long-QT Syndrome.
    Limpitikul WB; Dick IE; Tester DJ; Boczek NJ; Limphong P; Yang W; Choi MH; Babich J; DiSilvestre D; Kanter RJ; Tomaselli GF; Ackerman MJ; Yue DT
    Circ Res; 2017 Jan; 120(1):39-48. PubMed ID: 27765793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent regulation of ryanodine receptor 2 calcium release channels by arrhythmogenic human calmodulin missense mutants.
    Hwang HS; Nitu FR; Yang Y; Walweel K; Pereira L; Johnson CN; Faggioni M; Chazin WJ; Laver D; George AL; Cornea RL; Bers DM; Knollmann BC
    Circ Res; 2014 Mar; 114(7):1114-24. PubMed ID: 24563457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calmodulin variant E140G associated with long QT syndrome impairs CaMKIIδ autophosphorylation and L-type calcium channel inactivation.
    Prakash O; Gupta N; Milburn A; McCormick L; Deugi V; Fisch P; Wyles J; Thomas NL; Antonyuk S; Dart C; Helassa N
    J Biol Chem; 2023 Jan; 299(1):102777. PubMed ID: 36496072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel calmodulin mutations associated with congenital long QT syndrome affect calcium current in human cardiomyocytes.
    Pipilas DC; Johnson CN; Webster G; Schlaepfer J; Fellmann F; Sekarski N; Wren LM; Ogorodnik KV; Chazin DM; Chazin WJ; Crotti L; Bhuiyan ZA; George AL
    Heart Rhythm; 2016 Oct; 13(10):2012-9. PubMed ID: 27374306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long QT syndrome-associated calmodulin variants disrupt the activity of the slowly activating delayed rectifier potassium channel.
    McCormick L; Wadmore K; Milburn A; Gupta N; Morris R; Held M; Prakash O; Carr J; Barrett-Jolley R; Dart C; Helassa N
    J Physiol; 2023 Sep; 601(17):3739-3764. PubMed ID: 37428651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing.
    Tester DJ; Kopplin LJ; Will ML; Ackerman MJ
    Heart Rhythm; 2005 Oct; 2(10):1099-105. PubMed ID: 16188589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrhythmogenic calmodulin E105A mutation alters cardiac RyR2 regulation leading to cardiac dysfunction in zebrafish.
    Da'as SI; Thanassoulas A; Calver BL; Beck K; Salem R; Saleh A; Kontogianni I; Al-Maraghi A; Nasrallah GK; Safieh-Garabedian B; Toft E; Nounesis G; Lai FA; Nomikos M
    Ann N Y Acad Sci; 2019 Jul; 1448(1):19-29. PubMed ID: 30937913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel calmodulin mutations associated with congenital arrhythmia susceptibility.
    Makita N; Yagihara N; Crotti L; Johnson CN; Beckmann BM; Roh MS; Shigemizu D; Lichtner P; Ishikawa T; Aiba T; Homfray T; Behr ER; Klug D; Denjoy I; Mastantuono E; Theisen D; Tsunoda T; Satake W; Toda T; Nakagawa H; Tsuji Y; Tsuchiya T; Yamamoto H; Miyamoto Y; Endo N; Kimura A; Ozaki K; Motomura H; Suda K; Tanaka T; Schwartz PJ; Meitinger T; Kääb S; Guicheney P; Shimizu W; Bhuiyan ZA; Watanabe H; Chazin WJ; George AL
    Circ Cardiovasc Genet; 2014 Aug; 7(4):466-74. PubMed ID: 24917665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calmodulin mutations associated with long QT syndrome prevent inactivation of cardiac L-type Ca(2+) currents and promote proarrhythmic behavior in ventricular myocytes.
    Limpitikul WB; Dick IE; Joshi-Mukherjee R; Overgaard MT; George AL; Yue DT
    J Mol Cell Cardiol; 2014 Sep; 74():115-24. PubMed ID: 24816216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome sequencing and systems biology converge to identify novel mutations in the L-type calcium channel, CACNA1C, linked to autosomal dominant long QT syndrome.
    Boczek NJ; Best JM; Tester DJ; Giudicessi JR; Middha S; Evans JM; Kamp TJ; Ackerman MJ
    Circ Cardiovasc Genet; 2013 Jun; 6(3):279-89. PubMed ID: 23677916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctive malfunctions of calmodulin mutations associated with heart RyR2-mediated arrhythmic disease.
    Vassilakopoulou V; Calver BL; Thanassoulas A; Beck K; Hu H; Buntwal L; Smith A; Theodoridou M; Kashir J; Blayney L; Livaniou E; Nounesis G; Lai FA; Nomikos M
    Biochim Biophys Acta; 2015 Nov; 1850(11):2168-76. PubMed ID: 26164367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrhythmogenic calmodulin mutations disrupt intracellular cardiomyocyte Ca2+ regulation by distinct mechanisms.
    Yin G; Hassan F; Haroun AR; Murphy LL; Crotti L; Schwartz PJ; George AL; Satin J
    J Am Heart Assoc; 2014 Jun; 3(3):e000996. PubMed ID: 24958779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calmodulin Mutations in Human Disease.
    Hussey JW; Limpitikul WB; Dick IE
    Channels (Austin); 2023 Dec; 17(1):2165278. PubMed ID: 36629534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel long QT syndrome-associated missense mutation, L762F, in CACNA1C-encoded L-type calcium channel imparts a slower inactivation tau and increased sustained and window current.
    Landstrom AP; Boczek NJ; Ye D; Miyake CY; De la Uz CM; Allen HD; Ackerman MJ; Kim JJ
    Int J Cardiol; 2016 Oct; 220():290-8. PubMed ID: 27390944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single Construct Suppression and Replacement Gene Therapy for the Treatment of All
    Hamrick SK; Kim CSJ; Tester DJ; Gencarelli M; Tobert KE; Gluscevic M; Ackerman MJ
    Circ Arrhythm Electrophysiol; 2024 Aug; 17(8):e012036. PubMed ID: 39069900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allele-specific ablation rescues electrophysiological abnormalities in a human iPS cell model of long-QT syndrome with a CALM2 mutation.
    Yamamoto Y; Makiyama T; Harita T; Sasaki K; Wuriyanghai Y; Hayano M; Nishiuchi S; Kohjitani H; Hirose S; Chen J; Yokoi F; Ishikawa T; Ohno S; Chonabayashi K; Motomura H; Yoshida Y; Horie M; Makita N; Kimura T
    Hum Mol Genet; 2017 May; 26(9):1670-1677. PubMed ID: 28335032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.